Mumbai sees 1,266 new cases, 36 Covid deaths
There has been a drop in the number of Covid-19 cases across Maharashtra on Friday
There has been a drop in the number of Covid-19 cases across Maharashtra on Friday, with 21,273 new infections and 425 Covid deaths being reported in the last 24 hours, pushing its tally to 56,72,180 with 92,225 fatalities till now. It is the lowest single-day case reported since March this year.
Mumbai has witnessed a slight drop in the number of Covid cases on Monday, with 1,266 new infections and 36 Covid deaths being reported in the last 24 hours, increasing its total count to 7,02,532, with 14,778 fatalities till now. The recovery rate has increased to 94 per cent with 855 being recovered and discharged across the city, taking the total recovery count to 6,57,301.
India News: First-dose recipients of Covaxin don't need to restart their vaccination schedule if the gap between doses goes beyond the recommended 4-6 week interv
The first dose remains in the body but also has its own limited half-life. All antibodies produced are proteins that get degraded within the body whether used or not used. “So, the immune response generated by the first dose may possibly start tapering off after 4-5 months,” Bal added. The duration between two Covishield doses was increased from 4 weeks to 12 weeks primarily based on data from international trials where after a first dose the immune response was measured until the second dose was given. “In some cases, due to trial related issues, the second dose was given as late as 12 weeks and still the effect of the first dose was pretty much okay,” she added.
The first dose remains in the body but also has its own limited half-life. All antibodies produced are proteins that get degraded within the body whether used or not used. “So, the immune response generated by the first dose may possibly start tapering off after 4-5 months,” Bal added. The duration between two Covishield doses was increased from 4 weeks to 12 weeks primarily based on data from international trials where after a first dose the immune response was measured until the second dose was given. “In some cases, due to trial related issues, the second dose was given as late as 12 weeks and still the effect of the first dose was pretty much okay,” she added.